Authors
Latest:
Treatment of Diabetes in Older Adults: Guideline HighlightsThe Numbers: >90% of US adults aged ≥65 yrs have diabetes; 33% of those have T2DM; ~50% of older adults have prediabetes. We highlight new Endocrine Society treatment guidance.
Latest:
Pruritic Papulovesicular Rash on Lower Legs: Your Dx?Here are key clues: an intensely pruritic rash on the lower legs that developed within hours after the patient walked through a grassy field near a lake.
Latest:
Pruritic Papulovesicular Rash on Lower Legs: Your Dx?Here are key clues: an intensely pruritic rash on the lower legs that developed within hours after the patient walked through a grassy field near a lake.
Latest:
FDA Reviewing New Prefilled Syringe Formulation for GSK’s ShingrixAn FDA decision on GSK's Shingrix application is expected by June 20, 2025.
Latest:
Expanding Leg Ulcer in a Young WomanSelf-treatment has done nothing to slow the progress of this lesion which the patient thought might be an insect bite at first. Your Dx?
Latest:
Top 3 Atrial Fibrillation Studies in 2018Andexxa, CABANA, and new AF score. Cardiologist and Patient Care author Payal Kohli, MD, highlights 3 pivotal developments from 2018.
Latest:
Vaping-related Hospitalization, Mortality: A Quiz on New CDC GuidanceTry your hand at these 8 questions based on the latest CDC guidance on rehospitalization and mortality in patients with vaping-related lung injury.
Latest:
New COPD Drugs: 2019 in ReviewFDA 2019 approvals for COPD treatment included a cryotherapy spray and other novel & breakthrough therapies. Updates at-a-glance, here.
Latest:
Elevated Phosphorous in CKD: How to Avoid Vascular CalcificationThe optimal choice of medication to bind excess phosphate in patients with advanced CKD won't always be straightforward.
Latest:
Considering Aspirin: 8 Questions on Primary CVD PreventionThe role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.
Latest:
EVAPORATE: Icosapent Ethyl Added to Statins Slowed Coronary Atherosclerosis ProgressionAHA Scientific Sessions 2019: Early results from the EVAPORATE study suggest promise for icosapent ethyl as add-on therapy in patients with high TGs already taking statins.
Latest:
4 Dangerous Holiday Food-Drug InteractionsWith the holiday season in full swing, you will want to remind your patients of these 4 hazardous holiday food and drug interactions.
Latest:
Risk-Based Kidney Care May Be On the WayNew risk prediction models may help identify patients with and without diabetes at elevated risk for chronic kidney disease, say authors of a recent study.
Latest:
ADPKD Quiz: Questions on Disease ProgressionThe risk for end-stage renal disease in patients with ADPKD is high. What factors increase the risk and how is it best managed? Test yourself.
Latest:
Breast Cancer Screening: A Conversation with Mette Kalager, MDACP 2025: Dr Kalager shares strategies for addressing patient beliefs, presenting risk data, and promoting shared decision-making in primary care settings.
Latest:
A Confluent, Crusty RashHow would you approach diagnosis of this widespread, nonpruritic rash? Lab work? Skin tests? Or will history and physical findings suffice?
Latest:
Optimizing Treatment for Patients With IBDA glance at therapeutic strategies being investigated to improve the treatment and outcomes of patients with ulcerative colitis and Crohn disease.
Latest:
Kidney Disease: Three Studies At-a-GlanceHighlighted: Chronic kidney disease and stroke risk, syphilis in ESRD patients, and how healthy diets may reduce CKD incidence.
Latest:
Rx Shorts: August 2018Ongoing Shingrix shortage, thyroid medication recalled, reduced opioid manufacturing, and more Rx updates that could impact your practice.
Latest:
FDA Approves Omlyclo as First Interchangeable Omalizumab BiosimilarOmlyclo is indicated for the treatment of moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, IgE-mediated food allergy, and chronic spontaneous urticaria.
Latest:
Hyperbilirubinemia and Diffuse Skin Lesions in a Woman with Diabetes, CVDCan you identify the cause of the hyperpigmented umbilicated lesions seen bilaterally on the patient's extremities and on her back?
Latest:
Hyperbilirubinemia and Diffuse Skin Lesions in a Woman with Diabetes, CVDCan you identify the cause of the hyperpigmented umbilicated lesions seen bilaterally on the patient's extremities and on her back?
Latest:
Is Medication Adherence a True Quality Indicator of CF Center Performance?Measures used to assess medication adherence in cystic fibrosis patients may overestimate use of therapy, according to results of a new study.
Latest:
Consider Coronary Artery Calcium: 7 QuestionsHow current are you on CAC and its place in CVD risk assessment? This short quiz will reveal your score.
Latest:
Considering Aspirin: 8 Questions on Primary CVD PreventionThe role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.
Latest:
Can Telehealth Bridge Disparities in Access to Pulmonary Rehab?DALLAS--In a session at the American Thoracic Society meeting this week study authors reported on gaps in post-discharge care for COPD and on tele-rehabilitation as possible bridge.
Latest:
Severe Asthma: A 5-question POP QuizSevere asthma affects 5% to 10% of adults with asthma. Find out what you know about diagnosis and treatment options for these patients with 5 no-nonsense questions.
Latest:
9 Questions on Primary CV Disease PreventionThe 2019 ACC/AHA guidelines on the primary prevention of cardiovascular disease could change your clinical practice. Try these 9 questions to find out how.
Latest:
Type 2 Diabetes: Clinical Suspicion and DiagnosisWho is at risk for T2DM? How often should you screen? What are the cut offs for Dx? Revisit the basics in 5 minutes or less.
